Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is a novel serum marker of cardiovascular risk: P103


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles